Methods for purification of messenger RNA

Patent metadata

Field	Value
Publication number	US-12084702-B2
Application number	US-202117450506-A
Country	US
Kind code	B2
Filing date	Oct 11, 2021
Priority date	Aug 24, 2018
Publication date	Sep 10, 2024
Grant date	Sep 10, 2024

Abstract

The present invention provides, among other things, methods for purifying mRNA based on normal flow filtration for therapeutic use.

First claim

The invention claimed is:

1. A method for purifying messenger RNA (mRNA) manufactured by in vitro transcription (IVT) synthesis, the method comprising the steps of:
(a) precipitating mRNA from a solution comprising one or more contaminants from manufacturing the mRNA to provide a suspension comprising precipitated mRNA;
(b) subjecting the suspension comprising the precipitated mRNA to a depth filter comprising three or more filter layers of a single three-dimensional matrix, or three or more filter layers of different three-dimensional matrices, wherein each of the three or more layers has a pore size that is smaller than the pore size of the preceding layer in the direction of flow and wherein the precipitated mRNA is retained by the depth filter;
(c) dissolving the precipitated mRNA retained by the depth filter in step (b) thereby allowing purified mRNA to pass through the depth filter; and
(d) recovering the purified mRNA from step (c);
wherein at least 1 gram of mRNA is purified per batch and the depth filter is made of an inert material that allows capture of the precipitated mRNA without clogging or forming a gel layer.

2. The method of claim 1 , wherein the IVT synthesis comprises a step of 5′-capping of the mRNA and/or a step of 3′-tailing of the mRNA.

3. The method of claim 1 , wherein the one or more contaminants from manufacturing the mRNA comprise:
(a) an enzyme,
(b) a salt, and/or
(c) short abortive transcripts.

4. The method of claim 1 , further comprising a step of washing the precipitated mRNA retained on the depth filter from step (b).

5. The method of claim 1 , wherein the depth filter comprises a filter screen.

6. The method of claim 1 , wherein the inert material is selected from the group comprising:
(a) polypropylene,
(b) modified polyether sulfone (mPES),
(c) polyether sulfone (PES),
(d) polyvinylidene fluoride (PVDF),
(e) cellulose,
(f) diatomaceous earth,
(g) polytetrafluoroethylene (PTFE),
(h) nitrocellulose,
(i) polyethylene,
(j) polyacrylonitrile,
(k) polycarbonate, and
(l) nylon.

7. The method of claim 1 , wherein the three or more filter layers are made of a felt matrix, wherein the thickness of the felt ranges from 1-10 mm.

8. The method of claim 1 , wherein the recovery step comprises one or more of:
recirculation of water/buffer;
single pass flush of water/buffer; and
reverse flush of water/buffer.

9. The method of claim 1 , wherein the pore size in each of the three or more layers is decreased by at least 10% than the pore size of the preceding layer in the direction of flow.

10. The method of claim 1 , wherein the depth filter has a surface area of or greater than about 100 cm 2 .

11. The method of claim 1 , wherein the depth filter has a surface area of or greater than about 1,000 cm 2 .

12. A method of purifying messenger RNA (mRNA) manufactured by in vitro transcription (IVT) synthesis, the method comprising:
(a) precipitating mRNA from a solution comprising one or more contaminants from manufacturing the mRNA to provide a suspension comprising precipitated mRNA;
(b) purifying the mRNA by subjecting the suspension comprising the precipitated mRNA to a purification system consisting essentially of one or more steps of filtration through a depth filter, wherein at least 1 gram of mRNA is purified per batch and the depth filter comprises three or more filter layers of a single three-dimensional matrix, or three or more filter layers of different three-dimensional matrices, is made of an inert material, wherein each of the three or more layers has a pore size that is smaller than the pore size of the preceding layer in the direction of flow; and
wherein the purified mRNA has a clinical grade purity without further purification.

13. The method of claim 12 , wherein the purified mRNA:
(a) comprises 5% or less, 4% or less, 3% or less, 2% or less, 1% or less or is substantially free of protein contaminants as determined by capillary electrophoresis,
(b) comprises less than 5%, less than 4%, less than 3%, less than 2%, less than 1%, or is substantially free of salt contaminants as determined by HPLC,
(c) comprises 5% or less, 4% or less, 3% or less, 2% or less, 1% or less or is substantially free of short abortive transcript contaminant as determined by HPLC, and/or
(d) has integrity of 95% or greater, 96% or greater, 97% or greater, 98% or greater, or 99% or greater as determined by capillary electrophoresis.

14. The method of claim 12 , wherein the pore size in each of the three or more layers is decreased by at least 10% than the pore size of the preceding layer in the direction of flow.

15. The method of claim 12 , wherein the depth filter has a surface area of or greater than about 100 cm 2 .

16. The method of claim 12 , wherein the depth filter has a surface area of or greater than about 100 cm 2 , or of or greater than about 1,000 cm 2 .

17. A method of purifying a composition comprising 100 grams or more of mRNA manufactured by in vitro transcription (IVT) synthesis, the method comprising:
(a) precipitating the IVT-transcribed mRNA comprising one or more contaminants from the IVT synthesis to generate a suspension;
(b) subjecting the suspension comprising the precipitated mRNA and contaminants to filtration through a depth filter, where the precipitated mRNA is retained by the depth filter, wherein the depth filter comprises three or more filter layers of a single three-dimensional matrix, or three or more filter layers of different three-dimensional matrices, wherein each of the three or more layers has a pore size that is smaller than the pore size of the preceding layer in the direction of flow;
wherein the depth filter is made of an inert material, and has a surface area of or greater than about 5,000 cm 2 ; and
(c) recovering the mRNA from the depth filter in a solution, thereby purifying the mRNA, wherein at least 85% of the mRNA is recovered and the recovered mRNA has integrity of 90% or greater and is substantially free of protein contaminants.

18. The method of claim 17 , wherein the pore size in each of the three or more layers is decreased by at least 10% than the pore size of the preceding layer in the direction of flow.

Assignees

• Translate Bio Inc

Inventors

• Parella Joseph
• Gillis Kimberly
• Abysalh Jonathan
• Jeannotte Travis
• Held Erik
• Derosa Frank
• Heartlein Michael
• Powell Rebecca

Classifications

• C12N15/1017 Primary

  by filtration, e.g. using filters, frits, membranes · CPC title

• C12N15/52

  Genes encoding for enzymes or proenzymes · CPC title

• B01D25/00

  Filters formed by clamping together several filtering elements or parts of such elements (disc filters B01D29/39) · CPC title

• C07H21/04

  with deoxyribosyl as saccharide radical · CPC title

• B01D37/00

  Processes of filtration (processes specially adapted for filtering gases B01D46/00) · CPC title